Bicocca Open Archive

Logo unimib boa
MANTOVANI, LORENZO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.357
AS - Asia 24.022
EU - Europa 16.989
SA - Sud America 3.385
AF - Africa 596
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 38
Totale 77.469
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.573
SG - Singapore 9.093
CN - Cina 4.431
IT - Italia 4.290
HK - Hong Kong 3.503
VN - Vietnam 3.360
RU - Federazione Russa 2.922
BR - Brasile 2.574
DE - Germania 2.195
IE - Irlanda 1.553
SE - Svezia 1.462
FR - Francia 964
GB - Regno Unito 882
UA - Ucraina 774
IN - India 701
CA - Canada 479
FI - Finlandia 457
ID - Indonesia 438
BD - Bangladesh 371
AR - Argentina 304
AT - Austria 288
TR - Turchia 287
NL - Olanda 284
KR - Corea 266
IQ - Iraq 245
MX - Messico 195
DK - Danimarca 189
JP - Giappone 184
PK - Pakistan 182
ZA - Sudafrica 176
ES - Italia 143
SA - Arabia Saudita 139
PH - Filippine 131
PL - Polonia 125
EC - Ecuador 111
VE - Venezuela 98
CH - Svizzera 92
UZ - Uzbekistan 89
MA - Marocco 88
CO - Colombia 87
IR - Iran 81
AU - Australia 68
CL - Cile 59
MY - Malesia 59
BE - Belgio 57
AE - Emirati Arabi Uniti 54
EG - Egitto 54
JO - Giordania 53
KE - Kenya 53
PY - Paraguay 53
TN - Tunisia 47
TH - Thailandia 45
ET - Etiopia 44
RO - Romania 40
CZ - Repubblica Ceca 38
NP - Nepal 38
UY - Uruguay 35
PE - Perù 33
TW - Taiwan 32
DZ - Algeria 30
EU - Europa 30
AL - Albania 27
BO - Bolivia 27
PT - Portogallo 27
JM - Giamaica 26
OM - Oman 26
LB - Libano 24
NG - Nigeria 23
IL - Israele 22
RS - Serbia 22
AZ - Azerbaigian 21
BG - Bulgaria 19
KZ - Kazakistan 19
LT - Lituania 19
GR - Grecia 16
SN - Senegal 16
KG - Kirghizistan 15
CR - Costa Rica 14
HU - Ungheria 14
LK - Sri Lanka 14
PS - Palestinian Territory 14
MD - Moldavia 13
NO - Norvegia 13
QA - Qatar 13
SI - Slovenia 13
BH - Bahrain 12
DO - Repubblica Dominicana 12
BY - Bielorussia 11
MN - Mongolia 11
NI - Nicaragua 11
NZ - Nuova Zelanda 11
GE - Georgia 10
HN - Honduras 10
KW - Kuwait 9
HR - Croazia 8
PA - Panama 8
LV - Lettonia 7
TT - Trinidad e Tobago 7
AO - Angola 6
BB - Barbados 6
Totale 77.324
Salva come PNG Salva come JPEG
Città #
Singapore 4.770
Ann Arbor 3.738
Hong Kong 3.447
Ashburn 2.732
San Jose 2.126
Fairfield 1.958
Woodbridge 1.679
Dublin 1.448
Chandler 1.435
Frankfurt am Main 1.285
Houston 1.251
Wilmington 1.178
Santa Clara 1.089
Milan 1.028
Ho Chi Minh City 997
New York 953
Seattle 874
Hanoi 822
Beijing 743
Jacksonville 741
Princeton 666
Cambridge 662
Dearborn 640
Chicago 622
The Dalles 592
Dallas 524
Los Angeles 512
Hefei 399
Lauterbourg 367
Council Bluffs 325
Jakarta 324
Altamura 302
Lawrence 293
Moscow 292
São Paulo 271
Nanjing 270
Helsinki 245
Seoul 235
Vienna 211
Buffalo 199
Rome 199
Shanghai 195
Boardman 157
San Diego 156
Guangzhou 155
Hangzhou 155
London 152
Munich 145
Orem 140
Nuremberg 139
Tokyo 139
Da Nang 131
Toronto 121
Haiphong 116
Lachine 104
Shenyang 103
Andover 100
Dong Ket 100
Nanchang 98
Rio de Janeiro 91
Baghdad 88
Saint Petersburg 87
Jinan 79
Fremont 76
Tashkent 76
Tianjin 76
Columbus 75
Lappeenranta 74
Salt Lake City 74
Warsaw 74
Changsha 73
Hebei 70
Dhaka 69
Chennai 68
Bologna 67
Montreal 64
Menlo Park 63
Johannesburg 62
Brooklyn 61
Zurich 61
Norwalk 60
Zhengzhou 60
Jiaxing 58
Ninh Bình 58
Biên Hòa 57
Brasília 57
Mexico City 56
Amsterdam 55
Mumbai 55
Ottawa 55
Phoenix 55
Falls Church 53
Denver 52
Lahore 52
New Delhi 52
Amman 50
Atlanta 50
Boston 50
Washington 50
Jeddah 47
Totale 47.460
Salva come PNG Salva come JPEG
Nome #
Costi dell’infarto miocardico acuto: analisi di dati sanitari amministrativi 950
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 550
Epidemiology of SLE in Italy: an observational study using a primary care database 542
Burden of Stroke in Europe: An Analysis of the Global Burden of Disease Study Findings from 2010 to 2019 515
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 465
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry 459
Administrative databases as a tool for identifying healthcare demand and costs in an over-one million population 458
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 442
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 441
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review 427
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 420
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors 403
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study 402
Distribution of Malocclusion Traits in the Pediatric Population of Milan: An Observational Study 392
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 386
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 377
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 376
Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation 367
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017 364
Inflammatory bowel diseases in italy: incidence trends and patients’ characteristics 356
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 355
Use of health care administrative databases to estimate the burden of breast cancer. 352
Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 351
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 346
Use of health care administrative databases to estimate the burden of multiple sclerosis: a population-based study 345
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy 345
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 344
Occupational exposure in the lombardy region (Italy) to sars-cov-2 infection: Results from the mustang–occupation–covid-19 study 342
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? 339
Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context 337
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT study) 334
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 331
Utilization, Outcomes and Costs of Implantable Cardioverter Defibrillators in Italy: A Population-Based Analysis Using Healthcare Administrative Databases 331
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 324
Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic 322
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 314
Health related quality of life in chronic liver diseases 313
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 309
Costs and effectiveness of influenza vaccination: A systematic review 304
Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study 301
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 300
The socioeconomic burden of patients affected by hemophilia with inhibitors 300
Global, regional, and national burden of suicide mortality 1990 to 2016: Systematic analysis for the Global Burden of Disease Study 2016 299
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 298
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 296
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 289
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 288
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 288
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 288
Impatto clinico ed economico della gestione dei rialzi pressori in gravidanza in regime di pronto soccorso: il possibile ruolo dei marcatori biochimici 287
The impact of liver disease on the health-related quality of life 284
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry 283
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 277
Estimates of the initial impact of the COVID-19 epidemic on overall mortality: evidence from Italy 276
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 275
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 274
Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting 274
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 274
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 274
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 273
Treatment of venous thromboembolism with tinzaparin in oncological patients 271
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 269
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 269
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 268
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 266
Health Related Quality of Life in the Major Liver Conditions 265
Sustainability of the Italian National Health Service 265
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 264
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 263
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 261
Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015 261
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 261
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 259
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 258
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 258
Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 258
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 257
The natural history of idiopathic pulmonary fibrosis in a large European population: the role of age, sex and comorbidities 257
Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017 253
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry 253
Difference in health related quality of life of chronic liver diseases and general population 250
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 249
Immune tolerance induction in patients with haemophilia a and inhibitors: Effectiveness and cost analysis in an European Cohort (The ITER Study) 248
Medical Costs And Resources Consumption In Patients With Atrial Fibrillation: An Italian Observational Study 247
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 246
COVID-19 and Obesity: Is Bariatric Surgery Protective? Retrospective Analysis on 2145 Patients Undergone Bariatric-Metabolic Surgery from High Volume Center in Italy (Lombardy) 246
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 245
Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016 245
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases 243
The economic impact of air pollution: a European assessment 243
Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions 242
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 241
Health related quality of life norm data of the general population in Italy: Results using the EQ-5D-3L and EQ-5D-5L instruments 240
Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis 240
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 239
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 238
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 238
Persistence and adherence to hypolipemic therapy in real practice: Results of a large administrative database 237
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 237
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 235
Totale 31.513
Salva come PNG Salva come JPEG
Categoria #
all - tutte 266.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 266.571
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021821 0 0 0 0 0 0 0 0 0 0 363 458
2021/20223.998 321 391 400 360 275 301 196 248 234 295 280 697
2022/20236.447 781 1.873 536 518 455 977 74 355 480 93 182 123
2023/20245.455 171 247 185 271 681 1.299 859 195 525 158 235 629
2024/202515.484 811 1.811 751 740 1.251 943 818 477 1.648 1.911 1.570 2.753
2025/202629.289 3.810 2.017 2.264 2.971 3.467 1.863 4.848 1.550 2.687 3.356 456 0
Totale 79.794